Sex and Estrous Cycle Differences in Analgesia and Brain Oxycodone Levels
- 28 September 2021
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 58 (12) , 6540-6551
Abstract
Sex differences in opioid analgesia occur in rodents and humans, and could be due to differences in drug and metabolite levels. Thus, we investigated the sex and cycle differences in analgesia (nociception) from oxycodone in rats and related these to sex and cycle differences in brain and plasma oxycodone and metabolite levels. Since numerous opioids are CYP2D enzyme substrates and variation in CYP2D alters opioid drug levels and response, we also initiated studies to see if the sex and cycle differences observed might be due to differences in brain CYP2D activity. Across oxycodone doses, females in diestrus had higher analgesia (using tail flick latency) compared to males and females in estrus; we also demonstrated a direct effect of estrous cycle on analgesia within females. Consistent with the analgesia, females in diestrus had highest brain oxycodone levels (assessed using microdialysis) compared to males and females in estrus. Analgesia correlated with brain oxycodone, but not brain oxymorphone or noroxycodone levels, or plasma drug or metabolite levels. Propranolol (a CYP2D mechanism–based inhibitor), versus vehicle pre-treatments, increased brain oxycodone, and decreased brain oxymorphone/oxycodone drug level ratios (an in vivo CYP2D activity phenotype in the brain) in males and females in estrus, but not in females in diestrus. Brain oxymorphone/oxycodone inversely correlated with analgesia. Together, both sex and estrous cycle impact oxycodone analgesia and brain oxycodone levels, likely through regulation of brain CYP2D oxycodone metabolism. As CYP2D6 is expressed in human brain, perhaps similar sex and cycle influences also occur in humans.Keywords
Funding Information
- Foundation for the National Institutes of Health (DA043526-01A1)
- Canadian Institutes of Health Research (Foundation grant FDN-154294)
- Centre for Addiction and Mental Health Foundation
This publication has 36 references indexed in Scilit:
- Sex Differences in Opioid Analgesia and Addiction: Interactions among Opioid Receptors and Estrogen ReceptorsMolecular Pain, 2013
- Morphine metabolism, transport and brain dispositionMetabolic Brain Disease, 2011
- Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 aloneBritish Journal of Clinical Pharmacology, 2010
- Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: Central mechanisms of action and roles of gonadal hormonesHormones and Behavior, 2010
- SEX DIFFERENCES IN THE PHARMACOKINETICS, OXIDATIVE METABOLISM AND ORAL BIOAVAILABILITY OF OXYCODONE IN THE SPRAGUE‐DAWLEY RATClinical and Experimental Pharmacology and Physiology, 2007
- In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics/PharmacodynamicsDrug Metabolism and Disposition, 2006
- Characterization of the antinociceptive effect of oxycodone in male and female ratsPharmacology Biochemistry and Behavior, 2006
- Morphine responses and experimental pain: Sex differences in side effects and cardiovascular responses but not analgesiaThe Journal of Pain, 2005
- Sex Differences in Morphine AnalgesiaAnesthesiology, 2000
- Afferent and efferent connections of the rat tail flick reflex (a model used to analyze pain control mechanisms)Journal of Comparative Neurology, 1982